Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits
- Author
- Mattias Van Heetvelde (UGent) , Mieke Van Bockstal (UGent) , Bruce Poppe (UGent) , Kathleen Lambein, Toon Rosseel (UGent) , Lilit Atanesyan, Dieter Deforce (UGent) , Ivo Van Den Berghe, Kim De Leeneer (UGent) , Jo Van Dorpe (UGent) , Anne Vral (UGent) and Kathleen Claes (UGent)
- Organization
- Keywords
- BRCA1, BRCA2, Methylation, Loss of heterozygosity, Tumor cell percentage, MUTATION CARRIERS, BRCA1, HETEROZYGOSITY, TUMORIGENESIS, PATHOLOGISTS, THERAPY, ALLELE, TUMORS, CELLS
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.86 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8558566
- MLA
- Van Heetvelde, Mattias, et al. “Accurate Detection and Quantification of Epigenetic and Genetic Second Hits in BRCA1 and BRCA2-Associated Hereditary Breast and Ovarian Cancer Reveals Multiple Co-Acting Second Hits.” CANCER LETTERS, vol. 425, 2018, pp. 125–33, doi:10.1016/j.canlet.2018.03.026.
- APA
- Van Heetvelde, M., Van Bockstal, M., Poppe, B., Lambein, K., Rosseel, T., Atanesyan, L., … Claes, K. (2018). Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits. CANCER LETTERS, 425, 125–133. https://doi.org/10.1016/j.canlet.2018.03.026
- Chicago author-date
- Van Heetvelde, Mattias, Mieke Van Bockstal, Bruce Poppe, Kathleen Lambein, Toon Rosseel, Lilit Atanesyan, Dieter Deforce, et al. 2018. “Accurate Detection and Quantification of Epigenetic and Genetic Second Hits in BRCA1 and BRCA2-Associated Hereditary Breast and Ovarian Cancer Reveals Multiple Co-Acting Second Hits.” CANCER LETTERS 425: 125–33. https://doi.org/10.1016/j.canlet.2018.03.026.
- Chicago author-date (all authors)
- Van Heetvelde, Mattias, Mieke Van Bockstal, Bruce Poppe, Kathleen Lambein, Toon Rosseel, Lilit Atanesyan, Dieter Deforce, Ivo Van Den Berghe, Kim De Leeneer, Jo Van Dorpe, Anne Vral, and Kathleen Claes. 2018. “Accurate Detection and Quantification of Epigenetic and Genetic Second Hits in BRCA1 and BRCA2-Associated Hereditary Breast and Ovarian Cancer Reveals Multiple Co-Acting Second Hits.” CANCER LETTERS 425: 125–133. doi:10.1016/j.canlet.2018.03.026.
- Vancouver
- 1.Van Heetvelde M, Van Bockstal M, Poppe B, Lambein K, Rosseel T, Atanesyan L, et al. Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits. CANCER LETTERS. 2018;425:125–33.
- IEEE
- [1]M. Van Heetvelde et al., “Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits,” CANCER LETTERS, vol. 425, pp. 125–133, 2018.
@article{8558566,
author = {{Van Heetvelde, Mattias and Van Bockstal, Mieke and Poppe, Bruce and Lambein, Kathleen and Rosseel, Toon and Atanesyan, Lilit and Deforce, Dieter and Van Den Berghe, Ivo and De Leeneer, Kim and Van Dorpe, Jo and Vral, Anne and Claes, Kathleen}},
issn = {{0304-3835}},
journal = {{CANCER LETTERS}},
keywords = {{BRCA1,BRCA2,Methylation,Loss of heterozygosity,Tumor cell percentage,MUTATION CARRIERS,BRCA1,HETEROZYGOSITY,TUMORIGENESIS,PATHOLOGISTS,THERAPY,ALLELE,TUMORS,CELLS}},
language = {{eng}},
pages = {{125--133}},
title = {{Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits}},
url = {{http://doi.org/10.1016/j.canlet.2018.03.026}},
volume = {{425}},
year = {{2018}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: